» Articles » PMID: 39851924

Optimal Pathways to Lung Cancer Screening in Primary Care Settings: A Scoping Review

Overview
Journal Curr Oncol
Publisher MDPI
Date 2025 Jan 24
PMID 39851924
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer is the leading cause of cancer-related deaths worldwide, and delayed detection contributes to poor outcomes. Primary care plays a crucial role in early diagnosis, but detecting lung cancer early remains challenging for general practitioners (GPs). Therefore, the aim of this scoping review was to identify optimal strategies and pathways for lung cancer screening (LCS) in primary care settings globally. We conducted a scoping review by searching PubMed, Scopus, and the Cochrane Library for relevant studies published in the past 10 years. Our keywords included "lung cancer", "primary care", "early detection", "screening", "best practices", and "pathways". We included randomized controlled trials, cross-sectional studies, and cohort studies focused on lung cancer screening in primary care. We extracted data on study characteristics, screening pathways, and key findings. We identified 18 studies that met our inclusion criteria. Important strategies for LCS included the use of shared decision-making tools, electronic health record (HER) prompts, risk prediction models, community outreach, and integration with smoking cessation programs. Barriers to implementation included the lack of provider familiarity with guidelines, time constraints, and patient factors. Healthcare professionals and policy makers in primary care settings can leverage this information to integrate the most effective screening strategies into their care, thus enhancing early detection rates and subsequently reducing global lung cancer morbidity and mortality.

References
1.
Wang G, Baggett T, Pandharipande P, Park E, Percac-Lima S, Shepard J . Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective. Radiology. 2019; 290(2):278-287. DOI: 10.1148/radiol.2018180212. View

2.
Kim Y, Lee J, Lee E, Lim J, Kim Y, Lee C . Strategies to Improve Smoking Cessation for Participants in Lung Cancer Screening Program: Analysis of Factors Associated with Smoking Cessation in Korean Lung Cancer Screening Project (K-LUCAS). Cancer Res Treat. 2023; 56(1):92-103. PMC: 10789955. DOI: 10.4143/crt.2022.1598. View

3.
Crosbie P, Gabe R, Simmonds I, Hancock N, Alexandris P, Kennedy M . Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial. Eur Respir J. 2022; 60(5). PMC: 9684623. DOI: 10.1183/13993003.00483-2022. View

4.
McCutchan G, Engela-Volker J, Anyanwu P, Brain K, Abel N, Eccles S . Assessing, updating and utilising primary care smoking records for lung cancer screening. BMC Pulm Med. 2023; 23(1):445. PMC: 10655268. DOI: 10.1186/s12890-023-02746-4. View

5.
Tildy B, McNeill A, Robins J, Dregan A, Richardson S, Brose L . How is nicotine vaping product (e-cigarette) use monitored in primary care electronic health records in the United Kingdom? An exploratory analysis of Clinical Practice Research Datalink (CPRD). BMC Public Health. 2023; 23(1):2263. PMC: 10655457. DOI: 10.1186/s12889-023-17200-7. View